SGLT2 Inhibitors Linked to Lower Age-Related Macular Degeneration Risk Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Linked to Lower Age-Related Macular Degeneration Risk
Most Adults on SGLT2 Inhibitors Require Therapy Adjustment Within a Year Tags SGLT-2 Inhibitor Read more about Most Adults on SGLT2 Inhibitors Require Therapy Adjustment Within a Year
Semaglutide Drives Significant Weight Loss in Asian Adults with Obesity Tags SGLT-2 Inhibitor Read more about Semaglutide Drives Significant Weight Loss in Asian Adults with Obesity
SGLT2i: First Choice of Treatment for all T2DM Patients or Not? Tags SGLT-2 Inhibitor Read more about SGLT2i: First Choice of Treatment for all T2DM Patients or Not?
New Living Guidelines for Diabetes Management Tags SGLT-2 Inhibitor Read more about New Living Guidelines for Diabetes Management
Study Highlights Need for Careful Insulin Adjustment and Monitoring of SGLT2 Inhibitors in Type 1 Diabetes Patients Tags short acting Intermediate acting Long acting Insulin syringes Insulin Pens Insulin Pumps SGLT-2 Inhibitor Read more about Study Highlights Need for Careful Insulin Adjustment and Monitoring of SGLT2 Inhibitors in Type 1 Diabetes Patients
GLP-1 Receptor Agonists May Improve Kidney Outcomes in Real-World Diabetes Care Compared to Most Alternatives, But Lag Behind SGLT2 Inhibitors Tags Diabetic Nephropathy SGLT-2 Inhibitor Read more about GLP-1 Receptor Agonists May Improve Kidney Outcomes in Real-World Diabetes Care Compared to Most Alternatives, But Lag Behind SGLT2 Inhibitors
POST-CABGDM: Efficacy And Safety Of Empagliflozin In Patients With Type 2 Diabetes Mellitus Undergoing Elective On-Pump Coronary Artery Bypass Grafting Tags Coronary artery disease SGLT-2 Inhibitor Read more about POST-CABGDM: Efficacy And Safety Of Empagliflozin In Patients With Type 2 Diabetes Mellitus Undergoing Elective On-Pump Coronary Artery Bypass Grafting
Vildagliptin Improves Glycemic Variability and Target Range in T2DM Patients on Premixed Insulin: A Controlled Study Tags Rapid acting Long acting SGLT-2 Inhibitor Read more about Vildagliptin Improves Glycemic Variability and Target Range in T2DM Patients on Premixed Insulin: A Controlled Study